Table 2 Surgical treatment and complications

Radiotherapy

0.822

 45 Gy

1 (4)

0

1 (10)

0

 45 Gy + 5.4 Gy

21 (91)

6 (86)

9 (90)

6 (100)

 50.5 Gy

1 (4)

1 (14)

0

0

Chemotherapy

3.2e⁻⁰⁵

 Xeloda®

22 (96)

7 (100)

9 (90)

6 (100)

 5-FU

1 (4)

0

1 (10)

0

Radiodermatitis

0.962

 −

7 (30)

2 (29)

3 (30)

2 (33)

 Non-severe

13 (57)

4 (57)

5 (50)

4 (67)

 Severe

3 (13)

1 (14)

2 (20)

0

Proctitis

0.211

 +

11 (48)

2 (29)

7 (70)

2 (33)

 −

12 (52)

5 (71)

3 (30)

4 (67)

Colitis

1

 +

0

0

0

0

 −

23 (100)

7 (100)

10 (100)

6 (100)

Mucositis

1

 +

0

0

0

0

 −

23 (100)

7 (100)

10 (100)

6 (100)

Surgical resection type

0.004

 Low anterior

17 (74)

7 (100)

8 (80)

2 (33)

 Abdomino-perineal

2 (9)

0

2 (20)

0

 Endo-anal

1 (4)

0

0

1 (17)

 Refused

3 (13)

0

0

3 (50)

Surgery delay

 Median

8.6 ± 2.8

9.3 ± 2.7

8.3 ± 3.1

8.1 ± 2.6

 Range

1.4–13.1

5.3–13.1

1.4–12.9

6.0–11.0